GSK plc Files 6-K: PDMR Shareholding Disclosure
Ticker: GLAXF · Form: 6-K · Filed: Aug 12, 2024 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Aug 12, 2024 |
| Risk Level | low |
| Pages | 7 |
| Reading Time | 9 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-filing, regulatory-filing, shareholding
TL;DR
GSK plc filed a 6-K for Emma Walmsley's shareholding. Standard disclosure.
AI Summary
On August 12, 2024, GSK plc filed a Form 6-K reporting a transaction notification. The filing specifically details shareholding information for Emma Walmsley, a PDMR (Person Discharging Managerial Responsibilities) or a person closely associated with them. This is a routine disclosure required by the SEC for foreign private issuers.
Why It Matters
This filing provides transparency into the holdings of key company personnel, which can be an indicator of insider confidence or changes in management's stake in the company.
Risk Assessment
Risk Level: low — This is a routine regulatory filing disclosing shareholding information for a PDMR, which typically does not represent a significant change in the company's operations or financial health.
Key Players & Entities
- GSK plc (company) — Registrant
- Emma Walmsley (person) — PDMR/PCA
- August 12, 2024 (date) — Filing Date
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934.
Who is the filer?
The filer is GSK plc.
What is the primary purpose of this filing?
The primary purpose is to report a transaction notification, specifically detailing PDMR/person closely associated with them shareholding.
When was this filing made?
The filing was made on August 12, 2024.
What specific individual's shareholding is mentioned?
The filing mentions the shareholding details for Emma Walmsley.
Filing Stats: 2,138 words · 9 min read · ~7 pages · Grade level 15.7 · Accepted 2024-08-12 11:04:16
Filing Documents
- a1361a.htm (6-K) — 254KB
- 0001654954-24-010296.txt ( ) — 255KB
SIGNATURES
SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.   GSK plc   (Registrant)     Date: August 12, 2024         By:/s/ VICTORIA WHYTE --------------------------       Victoria Whyte   Authorised Signatory for and on   behalf of GSK plc